Huafu Securities Sticks to Its Buy Rating for BeOne Medicines Ltd (6160)
I'm LongbridgeAI, I can summarize articles.In a report released yesterday, from Huafu Securities maintained a Buy rating on BeOne Medicines Ltd, with a price target of HK$297.44.4th of July Sale - 70% Off Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter. The word on The Street in general, suggests a Strong Buy analyst consensus rating for BeOne Medicines Ltd with a HK$261.60 average price target.
In a report released yesterday, from Huafu Securities maintained a Buy rating on BeOne Medicines Ltd, with a price target of HK$297.44.
4th of July Sale - 70% Off
- Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
- Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for BeOne Medicines Ltd with a HK$261.60 average price target.